Join Cole's Team

Read Cole’s story to find out how you can help his mom make his last wishes come true.
Read More...
Learn About Neuroendocrine Tumors (NETs)
diagnosis, treatment, research & survivorship.
NETS Info
Previous
Next

Honoring the life and spirit of your loved one.

The Neuroendocrine Tumor Research Foundation (NETRF) offers information and education to those with neuroendocrine tumors. NETRF is the leading private funder of research into causes and treatments of neuroendocrine tumors (NETs) in the search for a cure. 

How we work to end NETs

Dedicated to Curing Neuroendocrine TUMORS

$30M
Million in NET research funding

87¢ 
of every dollar spent in 2020 supported research and education.

43
Ongoing studies in 10 countries

NETRF News

Research Spotlight: Rodney Hicks, MD

Peptide receptor radionuclide therapy, or PRRT, has been available as a treatment option for some forms of neuroendocrine tumors – particularly for those NETs expressing the somatostatin receptor-2 (SSTR2) protein.

NETRF Announces Changes to its Board of Scientific Advisors

The Neuroendocrine Tumor Research Foundation (NETRF) recently announced changes to the Board of Scientific Advisors (BOSA), extending its sincerest appreciation for the participation of Dung Thi Le, MD, and welcoming Jennifer Eads, MD

spark-hope

Thank you for Sparking Hope in Neuroendocrine Tumor Research.

You helped us reach our $10 million goal. Learn how your gift is helping to spark NET research.

Get Involved

You can support a brighter future. Make a gift. Host an event. Or volunteer to help us advance our understanding of neuroendocrine tumors.

Join Our Mailing List

Learn about neuroendocrine tumor tests, treatments, and research. Find out about educational and inspirational events in the NET community.

NET Events

NETRF hosts free patient and caregiver neuroendocrine tumor conferences to educate and empower individuals to be part of their care planning and live their best life.

View events page

Next upcoming event:

Know Your NETs Virtual Conference
Saturday, October 10
9 am – 1 pm ET

Register Now